sb 220025 and Asthma
sb 220025 has been researched along with Asthma in 1 studies
SB 220025: inhibits p38 mitogen-activated protein kinase; structure in first source
SB220025 : Am member of the class of imidazoles carrying piperidin-4-yl, 4-fluophenyl and 2-aminopyrimidin-4-yl substituents at posiitons 1, 4 and 5 respectively.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Seow, CJ | 1 |
| Chue, SC | 1 |
| Duan, W | 1 |
| Yeo, KS | 1 |
| Koh, AH | 1 |
| Wong, WS | 1 |
Other Studies
1 other study available for sb 220025 and Asthma
| Article | Year |
|---|---|
Effects of inhibitors of the tyrosine signalling cascade on antigen challenge of guinea pig airways in vitro.
Topics: Animals; Asthma; Butadienes; Calcium-Calmodulin-Dependent Protein Kinases; Enzyme Inhibitors; Guinea | 2004 |